Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Feasibility of a subcutaneous gluteal turnover flap without donor site scar for perineal closure after abdominoperineal resection for rectal cancer.

Blok RD, Hagemans JAW, Burger JWA, Rothbarth J, van der Bilt JDW, Lapid O, Hompes R, Tanis PJ.

Tech Coloproctol. 2019 Aug;23(8):751-759. doi: 10.1007/s10151-019-02055-1. Epub 2019 Aug 20.

2.

Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma.

Hagemans JAW, Rothbarth J, van Bogerijen GHW, van Meerten E, Nuyttens JJME, Verhoef C, Burger JWA.

Ann Surg Oncol. 2019 Apr;26(4):1134-1141. doi: 10.1245/s10434-019-07191-4. Epub 2019 Feb 6.

3.

The liver-first approach for locally advanced rectal cancer and synchronous liver metastases.

Nierop PMH, Verseveld M, Galjart B, Rothbarth J, Nuyttens JJME, van Meerten E, Burger JWA, Grünhagen DJ, Verhoef C.

Eur J Surg Oncol. 2019 Apr;45(4):591-596. doi: 10.1016/j.ejso.2018.12.007. Epub 2018 Dec 10.

PMID:
30554788
4.

Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.

Hagemans JAW, Rothbarth J, Kirkels WJ, Boormans JL, van Meerten E, Nuyttens JJME, Madsen EVE, Verhoef C, Burger JWA.

Eur J Surg Oncol. 2018 Oct;44(10):1548-1554. doi: 10.1016/j.ejso.2018.06.033. Epub 2018 Jul 20.

PMID:
30075979
5.

Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.

Hagemans JAW, Blinde SE, Nuyttens JJ, Morshuis WG, Mureau MAM, Rothbarth J, Verhoef C, Burger JWA.

Ann Surg Oncol. 2018 Jul;25(7):1970-1979. doi: 10.1245/s10434-018-6483-9. Epub 2018 Apr 24.

6.

Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres.

de Leede EM, Burgmans MC, Kapiteijn E, Luyten GP, Jager MJ, Tijl FG, Hartgrink HH, Grünhagen DJ, Rothbarth J, van de Velde CJ, Verhoef C, Vahrmeijer AL.

Melanoma Res. 2016 Dec;26(6):588-594.

PMID:
27513071
7.

Posttreatment Surveillance in Patients with Prolonged Disease-Free Survival After Resection of Colorectal Liver Metastasis.

Galjart B, van der Stok EP, Rothbarth J, Grünhagen DJ, Verhoef C.

Ann Surg Oncol. 2016 Nov;23(12):3999-4007. Epub 2016 Jul 8.

8.

Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.

Doebar SC, de Monyé C, Stoop H, Rothbarth J, Willemsen SP, van Deurzen CH.

Breast. 2016 Jun;27:15-21. doi: 10.1016/j.breast.2016.02.014. Epub 2016 Mar 20.

PMID:
27212695
9.

The Prognostic Value of Post-operative Serum C-reactive Protein Level for -Survival after Surgery for Colorectal Liver Metastases.

van der Stok EP, Grünhagen DJ, Rothbarth J, Verhoef C.

Acta Chir Belg. 2015 Sep-Oct;115(5):348-55.

PMID:
26560001
10.

The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer.

Alberda WJ, Verhoef C, Schipper ME, Nuyttens JJ, Rothbarth J, de Wilt JH, Burger JW.

Dis Colon Rectum. 2015 Jul;58(7):677-85. doi: 10.1097/DCR.0000000000000388.

PMID:
26200682
11.

The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.

Ayez N, van der Stok EP, Grünhagen DJ, Rothbarth J, van Meerten E, Eggermont AM, Verhoef C.

Eur J Surg Oncol. 2015 Jul;41(7):859-67. doi: 10.1016/j.ejso.2015.04.012. Epub 2015 May 2.

PMID:
25979624
12.

[The treatment of locally recurrent rectal cancer].

Alberda WJ, Verhoef C, Nuyttens JJ, Rothbarth J, Burger JW.

Ned Tijdschr Geneeskd. 2015;159:A8199. Review. Dutch.

PMID:
25923493
13.

The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.

van der Stok EP, Grünhagen DJ, Alberda WJ, Reitsma M, Rothbarth J, Verhoef C.

Dig Surg. 2015;32(3):208-16.

PMID:
25896431
14.

[Curative resection of a solitary clavicular metastasis].

Vos E, Seynaeve C, Obdeijn IM, Mureau MA, Verhofstad MH, Rothbarth J.

Ned Tijdschr Geneeskd. 2014;158:A7296. Dutch.

PMID:
24823854
15.

Prophylactic nipple-sparing mastectomy leaves more terminal duct lobular units in situ as compared with skin-sparing mastectomy.

van Verschuer VM, van Deurzen CH, Westenend PJ, Rothbarth J, Verhoef C, Luiten EJ, Menke-Pluijmers MB, Koppert LB.

Am J Surg Pathol. 2014 May;38(5):706-12. doi: 10.1097/PAS.0000000000000180.

PMID:
24698963
16.

Intraoperative radiation therapy reduces local recurrence rates in patients with microscopically involved circumferential resection margins after resection of locally advanced rectal cancer.

Alberda WJ, Verhoef C, Nuyttens JJ, van Meerten E, Rothbarth J, de Wilt JH, Burger JW.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1032-40. doi: 10.1016/j.ijrobp.2014.01.014.

PMID:
24661656
17.

Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.

Alberda WJ, Verhoef C, Nuyttens JJ, Rothbarth J, van Meerten E, de Wilt JH, Burger JW.

Ann Surg Oncol. 2014 Feb;21(2):520-6. doi: 10.1245/s10434-013-3306-x. Epub 2013 Oct 12.

PMID:
24121879
18.

[Submucosal oesophageal tumours: diagnostics and treatment].

Rothbarth J, Verhoef CK, Poley JW, Biermann K, van Lanschot JJ, Wijnhoven BP.

Ned Tijdschr Geneeskd. 2012;156(33):A4549. Review. Dutch.

PMID:
22894805
19.

Lymphatic dissemination and the role of sentinel lymph node biopsy in early gastric cancer.

Rothbarth J, Wijnhoven BP.

Dig Surg. 2012;29(2):130-1. doi: 10.1159/000336457. Epub 2012 Apr 24. No abstract available.

20.

[Diagnostic image (357). A man with a knife in his back].

Sosef NL, Rothbarth J.

Ned Tijdschr Geneeskd. 2008 Jan 19;152(3):143. Dutch.

PMID:
18271460
21.

Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors.

Rothbarth J, Tollenaar RA, van de Velde CJ.

Expert Rev Anticancer Ther. 2006 Apr;6(4):553-65. Review.

PMID:
16613543
22.

Treatment of liver metastases of colorectal cancer.

Rothbarth J, van de Velde CJ.

Ann Oncol. 2005;16 Suppl 2:ii144-9. Review. No abstract available. Erratum in: Ann Oncol. 2006 Apr;17(4):727. Rothbarth, J [added].

PMID:
15958446
23.

Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.

Rothbarth J, Tollenaar RA, Schellens JH, Nortier JW, Kool LJ, Kuppen PJ, Mulder GJ, van de Velde CJ.

Eur J Cancer. 2004 Aug;40(12):1812-24. Review.

PMID:
15288282
24.

Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver.

Noter SL, Rothbarth J, Pijl ME, Keunen JE, Hartgrink HH, Tijl FG, Kuppen PJ, van de Velde CJ, Tollenaar RA.

Melanoma Res. 2004 Feb;14(1):67-72.

PMID:
15091197
25.

Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.

Rothbarth J, Koevoets C, Tollenaar RA, Tilby MJ, van de Velde CJ, Mulder GJ, Kuppen PJ.

Biochem Pharmacol. 2004 May 1;67(9):1771-8.

PMID:
15081876
26.

A systemic antitumor immune response prevents outgrowth of lung tumors after i.v. rechallenge but is not able to prevent growth of experimental liver tumors.

van Duijnhoven FH, Aalbers RI, Rothbarth J, Terpstra OT, Kuppen PJ.

Clin Exp Metastasis. 2004;21(1):13-8.

PMID:
15065598
27.

An experimental minimally invasive perfusion technique for the treatment of liver metastases.

Rothbarth J, Pijl ME, Tollenaar RA, Tijl F, Ivancev G, Mulder GJ, Kuppen PJ, van de Velde CJ, Schultze Kool LJ.

Eur J Surg Oncol. 2003 Nov;29(9):757-63.

PMID:
14602496
28.

Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver.

Rothbarth J, Pijl ME, Vahrmeijer AL, Hartgrink HH, Tijl FG, Kuppen PJ, Tollenaar RA, van de Velde CJ.

Br J Surg. 2003 Nov;90(11):1391-7.

PMID:
14598420
29.

Simple high-performance liquid chromatographic assay for melphalan in perfusate, rat liver and tumour tissue.

Sparidans RW, Silvertand L, Dost F, Rothbarth J, Mulder GJ, Schellens JH, Beijnen JH.

Biomed Chromatogr. 2003 Oct;17(7):458-64.

PMID:
14598330
30.

Melphalan antitumor efficacy and hepatotoxicity: the effect of variable infusion duration in the hepatic artery.

Rothbarth J, Woutersen RA, Sparidans RW, van de Velde CJ, Mulder GJ.

J Pharmacol Exp Ther. 2003 Jun;305(3):1098-103. Epub 2003 Feb 20.

PMID:
12606622
31.

Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.

Rothbarth J, Sparidans RW, Beijnen JH, Schultze-Kool LJ, Putter H, van de Velde CJ, Mulder GJ.

J Pharmacol Exp Ther. 2002 Nov;303(2):736-40.

PMID:
12388659
32.

Modulation of cytostatic efficacy of melphalan by glutathione: mechanisms and efficacy.

Rothbarth J, Vahrmeijer AL, Mulder GJ.

Chem Biol Interact. 2002 May 20;140(2):93-107. Review. No abstract available.

PMID:
12076518
33.

What is the impact of fecal incontinence on quality of life?

Rothbarth J, Bemelman WA, Meijerink WJ, Stiggelbout AM, Zwinderman AH, Buyze-Westerweel ME, Delemarre JB.

Dis Colon Rectum. 2001 Jan;44(1):67-71.

PMID:
11805565
34.

[Patient with eosinophilic polymyositis].

de Kruijf EJ, Rothbarth J, van Duinen SG, de Meijer PH, Meinders AE.

Ned Tijdschr Geneeskd. 2000 Oct 14;144(42):2019-23. Review. Dutch.

PMID:
11072522
35.

Long-term results of anterior anal sphincter repair for fecal incontinence due to obstetric injury / with invited commentaries.

Rothbarth J, Bemelman WA, Meijerink WJ, Buyze-Westerweel ME, van Dijk JG, Delemarre JB.

Dig Surg. 2000;17(4):390-3; discussion 394.

PMID:
11053947

Supplemental Content

Loading ...
Support Center